VAIL, CO
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)STEADMAN PHILIPPON RESEARCH INSTITUTE, founded in 1988, is a mid-sized nonprofit in the Medical Research sector that reported $14.2M in total revenue in fiscal year 2024. Expenses of $16.2M exceeded revenue, resulting in a 14% operating deficit.
BUILDING ON OUR LEGACY OF EXCELLENCE IN ORTHOPAEDIC SPORTS MEDICINE, SPRI IS UNLOCKING THE SECRETS OF HEALING, FINDING CURES AND ENHANCING LIVES THROUGH GLOBAL LEADERSHIP IN REGENERATIVE MEDICINE, SCIENTIFIC RESEARCH, INNOVATION AND EDUCATION.
CENTER FOR REGENERATIVE AND PERSONALIZED MEDICINE (CRPM) - CRPM IS COMMITTED TO CONDUCTING THE HIGHEST IMPACT TEAM SCIENCE, LEVERAGING THE EXPERTISE OF THE INSTITUTE'S OTHER SCIENTIFIC DEPARTMENTS...
CENTER FOR REGENERATIVE AND PERSONALIZED MEDICINE (CRPM) - CRPM IS COMMITTED TO CONDUCTING THE HIGHEST IMPACT TEAM SCIENCE, LEVERAGING THE EXPERTISE OF THE INSTITUTE'S OTHER SCIENTIFIC DEPARTMENTS. CRPM'S KEY AREA OF FOCUS IS TO ACCELERATE CLINICAL TRANSLATION AND HELP SCIENTIFIC DISCOVERIES AND PROVEN TREATMENTS GET TO PATIENTS FASTER. CRPM'S SCIENTIFIC PROGRAMS INVESTIGATE CELLULAR SCIENCE AND REGENERATIVE MEDICINE TECHNIQUES AND THERAPIES. THESE PROGRAMS ARE: FRACTURE REPAIR AND REGENERATIVE THERAPEUTICS MUSCLE REPAIR AND STEM CELL BIOLOGY BONE AND CARTILAGE REPAIR AND STEM CELL BIOLOGY GENETIC AND CELLULAR ENGINEERING STEM CELL ENGINEERING AND CARTILAGE REGENERATION HEALTH AGING DIAGNOSTICS
BIOMEDICAL ENGINEERING (BME) IS A MULTIDISCIPLINARY LABORATORY WHICH APPLIES QUANTITATIVE, ANALYTICAL, AND INTEGRATIVE METHODS TO THE FIELD OF ORTHOPAEDIC MEDICINE. THE MULTITALENTED RESEARCH STAFF...
BIOMEDICAL ENGINEERING (BME) IS A MULTIDISCIPLINARY LABORATORY WHICH APPLIES QUANTITATIVE, ANALYTICAL, AND INTEGRATIVE METHODS TO THE FIELD OF ORTHOPAEDIC MEDICINE. THE MULTITALENTED RESEARCH STAFF INTEGRATES CLINICAL CARE, RESEARCH, AND EDUCATION WITH THE RESOURCES OF WORLD-RENOWNED MEDICAL DOCTORS IN ORDER TO IMPROVE THE TREATMENT OF MUSCULOSKELETAL DISEASES. THIS FOCUSED APPROACH IS DESIGNED TO MAINTAIN AND ENHANCE ATHLETIC PERFORMANCE, HEALTH, AND QUALITY OF LIFE FOR THE PROFESSIONAL, SEMI-PROFESSIONAL, COLLEGIATE, HIGH SCHOOL AND THE RECREATIONALLY ACTIVE INDIVIDUAL THROUGH AN EMPHASIS ON BENCH-TO-BEDSIDE RESEARCH. SEE CONTINUATION ON SCHEDULE O. THE PROGRAMS PROVIDED BY THE DEPARTMENT OF BIOMEDICAL ENGINEERING ARE UNIQUE AND DIVERSE AND THEY ENCOMPASS A COMPLETE RANGE OF SERVICES FOR THE PHYSICALLY ACTIVE OR THOSE WISHING TO RETURN TO AN ACTIVE LIFESTYLE AFTER INJURY.
THE CENTER FOR OUTCOMES-BASED ORTHOPAEDIC RESEARCH (COOR) PURSUES PATIENT-CENTERED OUTCOMES RESEARCH, WHICH HAS BEEN DEFINED AS THE STUDY OF THE END RESULTS OF MEDICAL TREATMENT, WHICH IS INTENDED TO...
THE CENTER FOR OUTCOMES-BASED ORTHOPAEDIC RESEARCH (COOR) PURSUES PATIENT-CENTERED OUTCOMES RESEARCH, WHICH HAS BEEN DEFINED AS THE STUDY OF THE END RESULTS OF MEDICAL TREATMENT, WHICH IS INTENDED TO PROVIDE SCIENTIFIC EVIDENCE TO SUPPORT PATIENT AND PHYSICIAN DECISIONS REGARDING MEDICAL TREATMENT. THE INSTITUTE'S OUTCOMES RESEARCH IS BASED ON PHYSICIAN/PATIENT ASSESSMENT OF IMPROVEMENT IN FUNCTION, QUALITY OF LIFE AND PATIENT SATISFACTION. OUTCOMES RESEARCH PROVIDES A TOOL TO LINK THE PATIENT'S PERSPECTIVE TO THE EFFECTIVENESS OF HEALTH TREATMENT. THIS ALLOWS FOR INCREASED PARTICIPATION BY PATIENTS IN THE DECISION-MAKING PROCESS REGARDING THE KIND OF CARE THEY DESIRE. OUR GOAL IN COOR IS TO LEARN FROM PATIENTS AND VALIDATE TREATMENT PROTOCOLS IN AN EFFORT TO IMPROVE THE QUALITY OF HEALTH CARE FOR EVERY PATIENT.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $14,151,760 | $13,892,440 | +0.0% |
| Expenses | $16,201,121 | $16,176,377 | +0.0% |
| Net Income | $-2,049,361 | $-2,283,937 | -0.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| DAN DRAWBAUGH | CEO/PRESIDENT | 16.00 |
Officer
Director
|
$513,750 | $689 | $514,439 |
| DR MARC PHILIPPON | CO-CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ROBERT BOURNE | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| WILL COOK | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDY DALY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| TOM GORRIE | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DR TOM HACKETT | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| TED HARTLEY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBERT HURST | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| VANESSA KERZNER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DORIS KIRCHNER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRIS LINDLEY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DR PETER MILLETT | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| CYNTHIA L NELSON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MARY K NOYES | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SENENNE PHILIPPON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| STEVEN READ | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KEVIN RUDOLPH | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DAMARIS SKOURAS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| GEN PETE DAWKINS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| FRANK KRAUSER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| LARRY MULLEN JR | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| AL PERKINS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| ALEX RAMPELL | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| GARY S ROSENBACH | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KENNETH SCHANZER | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| MIKE SHANNON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| GAY L STEADMAN | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| GEOFF GRAY | CFO/TREASURER | 16.00 |
Officer
|
$160,405 | $6,406 | $166,811 |
| JOHNNY HUARD | CHIEF SCIENTIFIC OFFICER | 40.00 |
Highest
|
$646,016 | $15,810 | $661,826 |
| LEE JONES | VP OF DEVELOPMENT | 40.00 |
Highest
|
$343,296 | $12,499 | $355,795 |
| SCOTT TASHMAN | DEVELOPMENT DIRECTOR | 40.00 |
Highest
|
$291,489 | $20,839 | $312,328 |
| KRISTIN MORGAN | DIRECTOR OF PHILANTHROPY | 40.00 |
Highest
|
$189,292 | $9,886 | $199,178 |
| SUZANNE PAGE | VICE PRESIDENT OF OPERATIONS | 40.00 |
Highest
|
$296,394 | $12,707 | $309,101 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $14,151,760 | $16,201,121 | $14,362,541 | $-2,049,361 |
| 2023 | $13,892,440 | $16,176,377 | $15,741,993 | $-2,283,937 |
| 2022 | $13,468,545 | $15,373,731 | $17,123,463 | $-1,905,186 |
| 2021 | $15,214,073 | $14,167,484 | $14,955,351 | $1,046,589 |
| 2020 | $14,818,176 | $13,828,960 | $13,404,698 | $989,216 |
| 2019 | $12,009,426 | $12,604,271 | $12,820,509 | $-594,845 |
| 2018 | $12,979,703 | $10,614,487 | $13,169,994 | $2,365,216 |
Compare STEADMAN PHILIPPON RESEARCH INSTITUTE with other nonprofits in Colorado and across the country.